Haoxi Health Technology reports FY24 EPS 4c vs. 4c last year

Reports revenue $48.5M vs. $28.2M last year. Zhen Fan, CEO, stated that, “HAO has experienced financial growth in the fiscal year ended June 30, 2024, with net revenue increasing from $28.23 million in the fiscal year ended June 30, 2023 to $48.52 in the fiscal year ended June 30, 2024, reflecting a 72% increase. This growth is largely due to a rise in average revenue per client in 2024, which increased from $71,830 to $89,355, and an expanded customer base that grew from 393 to 543 clients. These results are attributed to our marketing strategies and the growing demand for our services, particularly in the healthcare sector. While costs rose in tandem with revenue, which increased from $26.17 million to $45.77 million, this was in line with our growth strategy to scale up sales. Gross profit improved to $2.75 million, though the margin dipped slightly to 5.7% due to competitive pressures. Overall, we achieved net income of $1.29 million for the fiscal year ended June 30, 2024, up from $0.97 million in the fiscal year ended June 30, 2023.”